Targeting sphingosine 1-phosphate receptor 3 inhibits T-cell exhaustion and regulates recruitment of proinflammatory macrophages to improve antitumor efficacy of CAR-T cells against solid tumor
Backgrounds Chimeric antigen receptor (CAR)-modified T cells (CAR-T) are limited in solid tumors due to the hostile tumor microenvironment (TME). Combination therapy could be a promising approach to overcome this obstacle. Recent studies have shown that sphingosine 1-phosphate receptor (S1PR)3 has t...
Saved in:
Main Authors: | Weiting Liao, Ge Gao, Xia He, Pei Shu, Qizhi Ma, Benxia Zhang, Diyuan Qin, Yongsheng Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-08-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/8/e006343.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The sphingosine‐1‐phosphate signaling pathway (sphingosine‐1‐phosphate and its receptor, sphingosine kinase) and epilepsy
by: Lin Wang, et al.
Published: (2025-02-01) -
Deletion of sphingosine 1-phosphate receptor 1 in myeloid cells reduces hepatic inflammatory macrophages and attenuates MASH
by: Gopanandan Parthasarathy, et al.
Published: (2025-02-01) -
Proinflammatory Effects of Diesel Exhaust Nanoparticles on Scleroderma Skin Cells
by: A. Mastrofrancesco, et al.
Published: (2014-01-01) -
Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential
by: Masayo Aoki, et al.
Published: (2016-01-01) -
Corrigendum to “Sphingosine-1-Phosphate Signaling in Immune Cells and Inflammation: Roles and Therapeutic Potential”
by: Masayo Aoki, et al.
Published: (2016-01-01)